Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 367

1.

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.

Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA.

J Clin Oncol. 2020 Jan 15:JCO1902757. doi: 10.1200/JCO.19.02757. [Epub ahead of print]

PMID:
31940221
2.

Rapid perceptual processing in two- and three-dimensional prostate images.

Treviño M, Turkbey B, Wood BJ, Pinto PA, Czarniecki M, Choyke PL, Horowitz TS.

J Med Imaging (Bellingham). 2020 Mar;7(2):022406. doi: 10.1117/1.JMI.7.2.022406. Epub 2020 Jan 3.

PMID:
31930156
3.

Augmented Radiologist Workflow Improves Report Value and Saves Time: A Potential Model for Implementation of Artificial Intelligence.

Do HM, Spear LG, Nikpanah M, Mirmomen SM, Machado LB, Toscano AP, Turkbey B, Bagheri MH, Gulley JL, Folio LR.

Acad Radiol. 2020 Jan;27(1):96-105. doi: 10.1016/j.acra.2019.09.014.

PMID:
31818390
4.

Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsy.

Sugano D, Sidana A, Jain AL, Calio B, Gaur S, Maruf M, Merino M, Choyke P, Turkbey B, Wood BJ, Pinto PA.

Int Urol Nephrol. 2019 Dec 5. doi: 10.1007/s11255-019-02354-4. [Epub ahead of print]

PMID:
31807974
5.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Der Heijden AGV, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A.

Eur Urol. 2020 Feb;77(2):223-250. doi: 10.1016/j.eururo.2019.09.035. Epub 2019 Nov 19.

PMID:
31753752
6.

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.

Horwich A, Babjuk M, Bellmunt J, Bruins HM, Reijke TM, Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, Bari B, Blok W, De Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Witjes JA.

Ann Oncol. 2019 Nov 1;30(11):1697-1727. doi: 10.1093/annonc/mdz296.

PMID:
31740927
7.

18F-fluciclovine PET or PSMA PET for prostate cancer imaging?

Turkbey B, Choyke PL.

Nat Rev Urol. 2020 Jan;17(1):9-10. doi: 10.1038/s41585-019-0255-6. No abstract available.

PMID:
31676885
8.

Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.

Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, Rosenkrantz AB, Rubenstein JN, Rukstalis DB, Taneja SS, Turkbey B.

J Urol. 2019 Oct 23:101097JU0000000000000617. doi: 10.1097/JU.0000000000000617. [Epub ahead of print]

PMID:
31642740
9.

Natural history and imaging in men with high genetic risk for developing prostate cancer.

Dahut WL, Couvillon A, Pinto PA, Turkbey B, Karzai F.

Can J Urol. 2019 Oct;26(5S2):7-8.

10.

Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.

Turkbey B, Czarniecki M, Shih JH, Harmon SA, Agarwal PK, Apolo AB, Citrin DE, Gulley JL, Harisinghani M, Madan RA, Metwalli AR, Paquette E, Pinto PA, Rais-Bahrami S, Rowe LS, Wood BJ, Jacobs PM, Lindenberg L, Dahut W, Choyke PL.

AJR Am J Roentgenol. 2020 Jan;214(1):105-113. doi: 10.2214/AJR.19.21264. Epub 2019 Oct 15.

PMID:
31613660
11.

Detecting Prostate Cancer with Deep Learning for MRI: A Small Step Forward.

Padhani AR, Turkbey B.

Radiology. 2019 Dec;293(3):618-619. doi: 10.1148/radiol.2019192012. Epub 2019 Oct 8. No abstract available.

PMID:
31596184
12.

Annual short report of the society of abdominal radiology prostate cancer disease-focused panel.

Turkbey B, Margolis D.

Abdom Radiol (NY). 2019 Dec;44(12):4000-4001. doi: 10.1007/s00261-019-02259-x. No abstract available.

PMID:
31587097
13.

Erratum: Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks system (Erratum).

Sumathipala Y, Lay N, Turkbey B, Smith C, Choyke PL, Summers RM.

J Med Imaging (Bellingham). 2019 Jul;6(3):039803. doi: 10.1117/1.JMI.6.3.039803. Epub 2019 Sep 27.

14.

A multiparametric magnetic resonance imaging-based virtual reality surgical navigation tool for robotic-assisted radical prostatectomy.

Mehralivand S, Kolagunda A, Hammerich K, Sabarwal V, Harmon S, Sanford T, Gold S, Hale G, Romero VV, Bloom J, Merino MJ, Wood BJ, Kambhamettu C, Choyke PL, Pinto PA, Türkbey B.

Turk J Urol. 2019 Sep 1;45(5):357-365. doi: 10.5152/tud.2019.19133.

15.

Apical periurethral transition zone lesions: MRI and histology findings.

Tuncer S, Mehralivand S, Harmon SA, Sanford T, Brown GT, Rowe LS, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Abdom Radiol (NY). 2019 Aug 29. doi: 10.1007/s00261-019-02194-x. [Epub ahead of print]

PMID:
31468153
16.

PI-RADS: Past, present, and future.

Gupta RT, Mehta KA, Turkbey B, Verma S.

J Magn Reson Imaging. 2019 Aug 8. doi: 10.1002/jmri.26896. [Epub ahead of print] Review.

PMID:
31397038
17.

PI-RADS version 2.1: one small step for prostate MRI.

Barrett T, Rajesh A, Rosenkrantz AB, Choyke PL, Turkbey B.

Clin Radiol. 2019 Nov;74(11):841-852. doi: 10.1016/j.crad.2019.05.019. Epub 2019 Jun 22. Review.

PMID:
31239107
18.

Fully automated prostate whole gland and central gland segmentation on MRI using holistically nested networks with short connections.

Cheng R, Lay N, Roth HR, Turkbey B, Jin D, Gandler W, McCreedy ES, Pohida T, Pinto P, Choyke P, McAuliffe MJ, Summers RM.

J Med Imaging (Bellingham). 2019 Apr;6(2):024007. doi: 10.1117/1.JMI.6.2.024007. Epub 2019 Jun 5.

PMID:
31205977
19.

PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.

Padhani AR, Barentsz J, Villeirs G, Rosenkrantz AB, Margolis DJ, Turkbey B, Thoeny HC, Cornud F, Haider MA, Macura KJ, Tempany CM, Verma S, Weinreb JC.

Radiology. 2019 Aug;292(2):464-474. doi: 10.1148/radiol.2019182946. Epub 2019 Jun 11.

PMID:
31184561
20.
21.

Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance.

Bloom JB, Lebastchi AH, Gold SA, Hale GR, Sanford T, Mehralivand S, Ahdoot M, Rayn KN, Czarniecki M, Smith C, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

BJU Int. 2019 Nov;124(5):768-774. doi: 10.1111/bju.14835. Epub 2019 Jun 26.

PMID:
31141307
22.

Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy.

Sugano D, Sidana A, Jain AL, Calio B, Gaur S, Maruf M, Merino M, Choyke P, Turkbey B, Wood BJ, Pinto PA.

Int Urol Nephrol. 2019 Aug;51(8):1349-1355. doi: 10.1007/s11255-019-02168-4. Epub 2019 May 16.

PMID:
31098818
23.

Artificial intelligence at the intersection of pathology and radiology in prostate cancer.

Harmon SA, Tuncer S, Sanford T, Choyke PL, Türkbey B.

Diagn Interv Radiol. 2019 May;25(3):183-188. doi: 10.5152/dir.2019.19125. Review.

24.

mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy.

Gold SA, VanderWeele DJ, Harmon S, Bloom JB, Karzai F, Hale GR, Marhamati S, Rayn KN, Mehralivand S, Merino MJ, Gulley JL, Bilusic M, Madan RA, Choyke PL, Turkbey B, Dahut W, Pinto PA.

Urol Oncol. 2019 Jun;37(6):352.e25-352.e30. doi: 10.1016/j.urolonc.2019.01.012. Epub 2019 Apr 15.

PMID:
31000430
25.

Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.

Greer MD, Shih JH, Lay N, Barrett T, Bittencourt L, Borofsky S, Kabakus I, Law YM, Marko J, Shebel H, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2019 Mar 27:1-8. doi: 10.2214/AJR.18.20536. [Epub ahead of print]

PMID:
30917023
26.

First-in-human phase 0 study of 111In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging.

Kurdziel KA, Mena E, McKinney Y, Wong K, Adler S, Sissung T, Lee J, Lipkowitz S, Lindenberg L, Turkbey B, Kummar S, Milenic DE, Doroshow JH, Figg WD, Merino MJ, Paik CH, Brechbiel MW, Choyke PL.

J Transl Sci. 2019 Apr;5(2). doi: 10.15761/JTS.1000269. Epub 2018 Jul 13.

27.

Deep neural maps for unsupervised visualization of high-grade cancer in prostate biopsies.

Sedghi A, Pesteie M, Javadi G, Azizi S, Yan P, Kwak JT, Xu S, Turkbey B, Choyke P, Pinto P, Wood B, Rohling R, Abolmaesumi P, Mousavi P.

Int J Comput Assist Radiol Surg. 2019 Jun;14(6):1009-1016. doi: 10.1007/s11548-019-01950-0. Epub 2019 Mar 23.

PMID:
30905010
28.

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.

Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC.

Eur Urol. 2019 Sep;76(3):340-351. doi: 10.1016/j.eururo.2019.02.033. Epub 2019 Mar 18. Review.

PMID:
30898406
29.

Prostate Imaging Reporting and Data System Version 2 for MRI of Prostate Cancer: Can We Do Better?

Sackett J, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2019 Mar 19:1-9. doi: 10.2214/AJR.19.21178. [Epub ahead of print]

PMID:
30888865
30.

Contemporary treatments in prostate cancer focal therapy.

Ahdoot M, Lebastchi AH, Turkbey B, Wood B, Pinto PA.

Curr Opin Oncol. 2019 May;31(3):200-206. doi: 10.1097/CCO.0000000000000515.

31.

Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks.

Sumathipala Y, Lay N, Turkbey B, Smith C, Choyke PL, Summers RM.

J Med Imaging (Bellingham). 2018 Oct;5(4):044507. doi: 10.1117/1.JMI.5.4.044507. Epub 2018 Dec 15. Erratum in: J Med Imaging (Bellingham). 2019 Jul;6(3):039803.

32.

Novel Imaging in Detection of Metastatic Prostate Cancer.

Smith CP, Laucis A, Harmon S, Mena E, Lindenberg L, Choyke PL, Turkbey B.

Curr Oncol Rep. 2019 Mar 5;21(4):31. doi: 10.1007/s11912-019-0780-8. Review.

PMID:
30834999
33.

A comparison of prostate cancer bone metastases on 18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion.

Harmon SA, Mena E, Shih JH, Adler S, McKinney Y, Bergvall E, Mehralivand S, Sowalsky AG, Couvillon A, Madan RA, Gulley JL, Eary J, Mease RC, Pomper MG, Dahut WL, Turkbey B, Lindenberg L, Choyke PL.

Oncotarget. 2018 Dec 28;9(102):37676-37688. doi: 10.18632/oncotarget.26481. eCollection 2018 Dec 28.

34.

Prostate Magnetic Resonance Imaging: Lesion Detection and Local Staging.

Turkbey B, Choyke PL.

Annu Rev Med. 2019 Jan 27;70:451-459. doi: 10.1146/annurev-med-053117-123215. Review.

PMID:
30691375
35.

When to Biopsy the Seminal Vesicles: A Validated Multiparametric Magnetic Resonance Imaging and Target Driven Model to Detect Seminal Vesicle Invasion in Prostate Cancer.

Gold SA, Shih JH, Rais-Bahrami S, Bloom JB, Vourganti S, Singla N, Baroni RH, Coker MA, Fialkoff J, Noschang J, Roehrborn CG, Turkbey B, Pinto PA; Collaborators.

J Urol. 2019 Jan 23. doi: 10.1097/JU.0000000000000112. [Epub ahead of print]

PMID:
30681511
36.

A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.

Mehralivand S, Shih JH, Harmon S, Smith C, Bloom J, Czarniecki M, Gold S, Hale G, Rayn K, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Radiology. 2019 Mar;290(3):709-719. doi: 10.1148/radiol.2018181278. Epub 2019 Jan 22.

PMID:
30667329
37.

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.

Bloom JB, Hale GR, Gold SA, Rayn KN, Smith C, Mehralivand S, Czarniecki M, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

J Urol. 2019 Jan;201(1):84-90. doi: 10.1016/j.juro.2018.07.051.

PMID:
30577395
38.

Intra- and interreader reproducibility of PI-RADSv2: A multireader study.

Smith CP, Harmon SA, Barrett T, Bittencourt LK, Law YM, Shebel H, An JY, Czarniecki M, Mehralivand S, Coskun M, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B.

J Magn Reson Imaging. 2019 Jun;49(6):1694-1703. doi: 10.1002/jmri.26555. Epub 2018 Dec 21.

PMID:
30575184
39.

Sentinel lymph node imaging in urologic oncology.

Mehralivand S, van der Poel H, Winter A, Choyke PL, Pinto PA, Turkbey B.

Transl Androl Urol. 2018 Oct;7(5):887-902. doi: 10.21037/tau.2018.08.23. Review.

40.

Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents.

Czarniecki M, Mena E, Lindenberg L, Cacko M, Harmon S, Radtke JP, Giesel F, Turkbey B, Choyke PL.

Transl Androl Urol. 2018 Oct;7(5):831-843. doi: 10.21037/tau.2018.08.03. Review.

41.

Detection of lymph node metastases in genitourinary cancers.

Turkbey B.

Transl Androl Urol. 2018 Oct;7(5):765. doi: 10.21037/tau.2018.09.13. No abstract available.

42.

A collaborative computer aided diagnosis (C-CAD) system with eye-tracking, sparse attentional model, and deep learning.

Khosravan N, Celik H, Turkbey B, Jones EC, Wood B, Bagci U.

Med Image Anal. 2019 Jan;51:101-115. doi: 10.1016/j.media.2018.10.010. Epub 2018 Oct 28.

43.

Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer.

Czarniecki M, Pesapane F, Wood BJ, Choyke PL, Turkbey B.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S453-S461. doi: 10.21037/tau.2018.05.15. Review.

44.

Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation.

Gaur S, Lay N, Harmon SA, Doddakashi S, Mehralivand S, Argun B, Barrett T, Bednarova S, Girometti R, Karaarslan E, Kural AR, Oto A, Purysko AS, Antic T, Magi-Galluzzi C, Saglican Y, Sioletic S, Warren AY, Bittencourt L, Fütterer JJ, Gupta RT, Kabakus I, Law YM, Margolis DJ, Shebel H, Westphalen AC, Wood BJ, Pinto PA, Shih JH, Choyke PL, Summers RM, Turkbey B.

Oncotarget. 2018 Sep 18;9(73):33804-33817. doi: 10.18632/oncotarget.26100. eCollection 2018 Sep 18.

45.

Magnetic Resonance Imaging-Based Prediction of Prostate Cancer Risk-Reply.

Mehralivand S, Shih J, Turkbey B.

JAMA Oncol. 2018 Nov 1;4(11):1625. doi: 10.1001/jamaoncol.2018.4234. No abstract available.

PMID:
30326079
46.

Imaging of distant metastases of prostate cancer.

Pesapane F, Czarniecki M, Suter MB, Turkbey B, Villeirs G.

Med Oncol. 2018 Sep 14;35(11):148. doi: 10.1007/s12032-018-1208-2. Review.

PMID:
30218382
47.

Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience.

Rayn KN, Hale GR, Bloom JB, Gold SA, Carvalho FLF, Mehralivand S, Czarniecki M, Wood BJ, Merino MJ, Choyke P, Türkbey B, Pinto PA, Agarwal PK.

Diagn Interv Radiol. 2018 Sep;24(5):316-320. doi: 10.5152/dir.2018.18102. Review.

48.

Editorial Comment.

Turkbey B.

J Urol. 2018 Nov;200(5):1028-1029. doi: 10.1016/j.juro.2018.06.084. Epub 2018 Aug 9. No abstract available.

PMID:
30098949
49.

Deep dense multi-path neural network for prostate segmentation in magnetic resonance imaging.

To MNN, Vu DQ, Turkbey B, Choyke PL, Kwak JT.

Int J Comput Assist Radiol Surg. 2018 Nov;13(11):1687-1696. doi: 10.1007/s11548-018-1841-4. Epub 2018 Aug 7.

50.

Alström syndrome: Renal findings in correlation with obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH clinical center.

Waldman M, Han JC, Reyes-Capo DP, Bryant J, Carson KA, Turkbey B, Choyke P, Naggert JK, Gahl WA, Marshall JD, Gunay-Aygun M.

Mol Genet Metab. 2018 Sep;125(1-2):181-191. doi: 10.1016/j.ymgme.2018.07.010. Epub 2018 Jul 24.

PMID:
30064963

Supplemental Content

Loading ...
Support Center